As it’s been in the limelight that the cases of coronavirus are increasing rapidly in India. It has become the most affected country in Asia. It is at the third place in the world chasing the US and Brazil. In view of it, on Thursday a drug firm Zydus Cadila said that it has launched Remdesivir under Remdac brand. It has been launched to cure the patients suffering from the symptoms of COVID-19.
COVID-19 Drug Firm Zydus Cadila Launches India’s Cheapest Remdesivir Verson At Rs 2,800
The price of the drug is just Rs 2,800 per 100 mg vial. Just after declaring of price, Remdac has become the cheapest Remdesivir brand of India. As per the distribution company, the drug will be available in the government and the private hospitals to treat the patients suffering from the severe crisis COVID-19.
Sharvil Patel, the Managing director of Cadila Health care says, Remdac is the drug that can be afforded by any of us and they would like to become successful to treat the patients with the help of this drug. Patel added to say that in this pandemic the company has supported the patients to treat them in this health crisis whether by developing vaccine or medicine when all the drugs are proven ineffective it came as the ray of hope for so many of us.
Before this, In June, Zydus dealt with Gilead Sciences Inc to developed and sale Remdesivir that has been prescribed to treat serious coronavirus patient. The interesting thing to be noticed is that Zydus Cadila is the participants of the race for COVID-19 vaccine and the petitioner ZyCov-D is now in phase II.
Now again, India has marked the highest number of COVID-19 cases in 24 hours that are 66,999. In India, the coronavirus cases are on its peak it has reached to 23,96,638, total active cases stand for 6,53,622 while 16,95,983 have been discharged. The number of death rate is less than discharged.
According to the Ministry of Health and Family Welfare, 942 deaths have been recorded within the last 24 hours and the death toll reached 47,033. The entire world is putting all their efforts to control the spread of COVID-19 virus but still, it seems not possible as daily new cases have been registered in the bulk. Stay connected with us.
